Clinical Trial Update: Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome [NA]

View source ↗

Summary

This clinical trial update reports that a study evaluating neuroprotective effects of risperidone in individuals with 22q11.2 Deletion Syndrome has been termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 22q11 Deletion Syndrome

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: University of Geneva, Switzerland | Conditions: 22q11.2 Deletion Syndrome | NA | Status: TERMINATED